logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. Devatis Inc.

    Devatis Inc. drugs

    FiltersReset Filters
    5 results

    • amoxicillin and clavulanate potassium

      (Amoxicillin and Clavulanate Potassium)
      Devatis Inc.
      Usage: Amoxicillin and clavulanate potassium for oral suspension is indicated for pediatric patients (3 months to 12 years) weighing ≤40 kg for treating recurrent or persistent acute otitis media caused by specific bacteria. It is not effective for certain strains of S. pneumoniae. Usage should consider susceptibility data to prevent resistance.

    • cyclosporine

      (cyclosporine)
      Devatis Inc.
      Usage: Cyclosporine ophthalmic emulsion is indicated for increasing tear production in patients with keratoconjunctivitis sicca, particularly when tear production is suppressed due to ocular inflammation. It is not effective in patients already using topical anti-inflammatory drugs or punctal plugs.

    • furosemide

      (furosemide)
      Devatis Inc.
      Usage: Furosemide is indicated for treating edema related to congestive heart failure, liver cirrhosis, and renal disease in both adults and children. It is also used as adjunctive therapy in acute pulmonary edema, particularly when rapid diuresis is needed or when oral administration is impractical.

    • lenalidomide

      (Lenalidomide)
      Devatis Inc.

    • pantoprazole sodium - pantoprazole sodium injection, powder, for solution

      (Pantoprazole Sodium)
      Devatis Inc.